AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances.

Koenig, Kristin L; Sahasrabudhe, Kieran D; Sigmund, Audrey M; Bhatnagar, Bhavana

Koenig, Kristin L; Sahasrabudhe, Kieran D; Sigmund, Audrey M; Bhatnagar, Bhavana.

Afiliação

Koenig KL; Division of Hematology, Department of Medicine, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Sahasrabudhe KD; Division of Hematology, Department of Medicine, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Sigmund AM; Division of Hematology, Department of Medicine, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Bhatnagar B; Division of Hematology, Department of Medicine, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

Genes (Basel) ; 11(8)2020 07 24.

Article em En | MEDLINE | ID: mdl-32722092

Assuntos

Citarabina/uso terapêutico; Daunorrubicina/uso terapêutico; Leucemia Mieloide Aguda/tratamento farmacológico; Síndromes Mielodisplásicas/tratamento farmacológico; Humanos; Leucemia Mieloide Aguda/complicações; Leucemia Mieloide Aguda/patologia; Síndromes Mielodisplásicas/complicações; Síndromes Mielodisplásicas/patologia; Prognóstico

Palavras-chave

CPX-351; acute myeloid leukemia with myelodysplasia-related changes; secondary AML

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google